Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A5

    
• • ·Information for Readers

    Page :A6

    

• Editorials

  • ·Oral anticoagulant prescription for atrial fibrillation in the Veterans Administration Health System: National and international differences

    Page :184-185

    John A. Cairns

    
  • ·Hospital readmissions after percutaneous coronary intervention aredeclining, but caution ahead is needed

    Page :192-194

    Varsha K. Tanguturi, Jason H. Wasfy

    Plan Plan

• Trial Designs

  • ·Rationale and design of the Randomized Evaluation of patients with Stable angina Comparing Utilization of noninvasive Examinations (RESCUE) trial

    Page :19-28

    Arthur E. Stillman, Constantine Gatsonis, João A.C. Lima, William C. Black, Jean Cormack, Ilana Gareen, Udo Hoffmann, Tao Liu, Kreton Mavromatis, Mitchell D. Schnall, James E. Udelson, Pamela K. Woodard

    Résumé Résumé Plan Plan  
  • ·Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial

    Page :59-68

    Michael D. Ezekowitz, Charles V. Pollack, Paul Sanders, Jonathan L. Halperin, Judith Spahr, Nilo Cater, William Petkun, Andrei Breazna, Paulus Kirchhof, Jonas Oldgren

    Résumé Résumé Plan Plan  
  • ·A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial : An Investigator-Initiated trial

    Page :69-76

    Antoinette de Waha, Sigrid Sandner, Moritz von Scheidt, Andreas Boening, Katharina Koch-Buettner, Dieter Hammel, Rainer Hambrecht, Bernhard C. Danner, Friedrich A. Schöndube, Gerold Goerlach, Theodor Fischlein, Michael Schmoeckel, Martin Oberhoffer, Rainer Schulz, Thomas Walther, Tibor Ziegelhöffer, Christoph Knosalla, Felix Schönrath, Friedhelm Beyersdorf, Matthias Siepe, Tim Attmann, Martin Misfeld, Friedrich-Wilhelm Mohr, Hans-Hinrich Sievers, Alexander Joost, Leon M. Putman, Günther Laufer, Christian Hamm, Uwe Zeymer, Adnan Kastrati, Peter W. Radke, Rüdiger Lange, Jochen Cremer, Heribert Schunkert

    Résumé Résumé Plan Plan
  • ·Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome

    Page :107-115

    Yongchen Hao, Jing Liu, Jun Liu, Sidney C. Smith, Yong Huo, Gregg C. Fonarow, Changsheng Ma, Junbo Ge, Kathryn A. Taubert, Louise Morgan, Yang Guo, Qian Zhang, Wei Wang, Dong Zhao, CCC-ACS Investigators

    Résumé Résumé Plan Plan   
  • ·Myocardial perfusion 320-row multidetector computed tomography–guided treatment strategy for the clinical management of patients with recent acute-onset chest pain : Design of the CArdiac cT in the treatment of acute CHest pain (CATCH)-2 randomized controlled trial

    Page :127-135

    Mathias Sørgaard, Jesper J. Linde, Jens D. Hove, Jan R. Petersen, Tem B.S. Jørgensen, Jawdat Abdulla, Merete Heitmann, Charlotte Kragelund, Thomas Fritz Hansen, Patricia M. Udholm, Christian Pihl, J. Tobias Kühl, Thomas Engstrøm, Jan Skov Jensen, Dan E. Høfsten, Henning Kelbæk, Klaus F. Kofoed

    Résumé Résumé Plan Plan  
  • ·Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH)

    Page :136-141

    Jens Jakob Thune, Steen Pehrson, Jens Cosedis Nielsen, Jens Haarbo, Lars Videbæk, Eva Korup, Gunnar Jensen, Per Hildebrandt, Flemming Hald Steffensen, Niels Eske Bruun, Hans Eiskjær, Axel Brandes, Anna Margrethe Thøgersen, Kenneth Egstrup, Jesper Hastrup-Svendsen, Dan Eik Høfsten, Christian Torp-Pedersen, Lars Køber

    Résumé Résumé Plan Plan
  • ·Rationale and design of a randomized trial of automated hovering for post–myocardial infarction patients: The HeartStrong program

    Page :166-174

    Andrea B. Troxel, David A. Asch, Shivan J. Mehta, Laurie Norton, Devon Taylor, Tirza A. Calderon, Raymond Lim, Jingsan Zhu, Daniel M. Kolansky, Brian M. Drachman, Kevin G. Volpp

    Résumé Résumé Plan Plan  
  • ·Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) – DEVOTE 1

    Page :175-183

    Steven P. Marso, Darren K. McGuire, Bernard Zinman, Neil R. Poulter, Scott S. Emerson, Thomas R. Pieber, Richard E. Pratley, Poul-Martin Haahr, Martin Lange, Kirstine Brown Frandsen, Rasmus Rabøl, John B. Buse

    Résumé Résumé Plan Plan

• Clinical Investigations

  • ·Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia

    Page :1-9

    Htet Khine, Wei Cheng Yuet, Beverley Adams-Huet, Zahid Ahmad

    Résumé Résumé Plan Plan  
  • ·Significant variation in P2Y₁₂ inhibitor use after peripheral vascular intervention in Medicare beneficiaries

    Page :10-18

    W. Schuyler Jones, Xiaojuan Mi, Laura G. Qualls, Ryan S. Turley, Sreekanth Vemulapalli, Eric D. Peterson, Manesh R. Patel, Lesley H. Curtis

    Résumé Résumé Plan Plan  
  • ·Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients

    Page :29-41

    Masaru Obokata, Hiroaki Sunaga, Hideki Ishida, Kyoko Ito, Tetsuya Ogawa, Yoshitaka Ando, Masahiko Kurabayashi, Kazuaki Negishi

    Résumé Résumé Plan Plan   
  • ·Predisposing cardiac conditions, interventional procedures, and antibiotic prophylaxis among patients with infective endocarditis

    Page :42-50

    Fabio Chirillo, Pompilio Faggiano, Moreno Cecconi, Antonella Moreo, Angelo Squeri, Oscar Gaddi, Enrico Cecchi, Italian Registry on Infective Endocarditis (RIEI) Investigators

    Résumé Résumé Plan Plan  
  • ·Utility of the LACE index at the bedside in predicting 30-day readmission or death in patients hospitalized with heart failure

    Page :51-58

    Payam Yazdan-Ashoori, Shun Fu Lee, Quazi Ibrahim, Harriette G.C. Van Spall

    Résumé Résumé Plan Plan   
  • ·Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial

    Page :77-86

    Rohan Shah, Anne Hellkamp, Yuliya Lokhnygina, Richard C. Becker, Scott D. Berkowitz, Günter Breithardt, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Keith A.A. Fox, Christopher C. Nessel, Kenneth W. Mahaffey, Jonathan P. Piccini, Daniel E. Singer, Manesh R. Patel, ROCKET AF Steering Committee Investigators

    Résumé Résumé Plan Plan   
  • ·Progressive intermediate-term improvement in ventricular and atrioventricular interaction after transcatheter pulmonary valve replacement in patients with right ventricular outflow tract obstruction

    Page :87-98

    Fatima I. Lunze, Babar S. Hasan, Kimberlee Gauvreau, David W. Brown, Steven D. Colan, Doff B. McElhinney

    Résumé Résumé Plan Plan   
  • ·Heart failure medications prescribed at discharge for patients with left ventricular assist devices

    Page :99-106

    Jacqueline Baras Shreibati, Shubin Sheng, Gregg C. Fonarow, Adam D. DeVore, Clyde W. Yancy, Deepak L. Bhatt, Phillip Schulte, Eric D. Peterson, Adrian Hernandez, Paul A. Heidenreich

    Résumé Résumé Plan Plan   
  • ·Outcomes and predictors of recovery in acute-onset cardiomyopathy: A single-center experience of patients undergoing endomyocardial biopsy for new heart failure

    Page :116-126

    Nisha A. Gilotra, Mosi K. Bennett, Adam Shpigel, Haitham M. Ahmed, Shaline Rao, Justin M. Dunn, Colleen Harrington, Tasha B. Freitag, Marc K. Halushka, Stuart D. Russell

    Résumé Résumé Plan Plan   
  • ·Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial

    Page :142-150

    Aruni Bhatnagar, Roberto Bolli, Brian H. Johnstone, Jay H. Traverse, Timothy D. Henry, Carl J. Pepine, James T. Willerson, Emerson C. Perin, Stephen G. Ellis, David X.M. Zhao, Phillip C. Yang, John P. Cooke, Robert C. Schutt, Barry H. Trachtenberg, Aaron Orozco, Micheline Resende, Ray F. Ebert, Shelly L. Sayre, Robert D. Simari, Lem Moyé, Christopher R. Cogle, Doris A. Taylor, Cardiovascular Cell Therapy Research Network (CCTRN)

    Résumé Résumé Plan Plan   
  • ·Impact of moderate physical activity on the longitudinal trajectory of a cardiac specific biomarker of injury: Results from a randomized pilot study of exercise intervention

    Page :151-156

    Christopher R. deFilippi, James A. de Lemos, Anne B. Newman, Jack M. Guralnik, Robert H. Christenson, Marco Pahor, Timothy Church, Mark Espeland, Stephen B. Krithevsky, Randall Stafford, Stephen L. Seliger, LIFE Study Group

    Résumé Résumé Plan Plan   
  • ·Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents

    Page :157-165

    Mineok Chang, Jung-Min Ahn, Nayoung Kim, Pil Hyung Lee, Jae-Hyung Roh, Sung-Han Yoon, Soo-Jin Kang, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park, Duk-Woo Park, Seung-Jung Park

    Résumé Résumé Plan Plan   
  • ·Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System

    Page :186-191

    Joshua Buck, Peter Kaboli, Brian F. Gage, Peter Cram, Mary S. Vaughan Sarrazin

    Résumé Résumé Plan Plan   
  • ·Readmission after inpatient percutaneous coronary intervention in the Medicare population from 2000 to 2012

    Page :195-203

    Christian McNeely, Stephen Markwell, Christina M. Vassileva

    Résumé Résumé Plan Plan